Beckman Coulter, Inc. is recalling 453 units of the Access Thyroglobulin assay (Catalog Number 33860) from lot 439163. This laboratory test, used to monitor patients for recurrent thyroid cancer, may generate incorrectly high results. Laboratory supervisors and healthcare providers should stop using the affected lot immediately and contact the manufacturer for a replacement.
Falsely increased test results may lead physicians to perform unnecessary diagnostic imaging studies or make inappropriate therapy adjustments in patients being monitored for residual or recurrent thyroid cancer.
Simultaneous one-step immunoenzymatic assay.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.